CEL-SCI
Junshi Biosciences
Coherus
Exelixis
Immutep S.A.S.
Merck Sharp & Dohme LLC
Iovance Biotherapeutics
BeiGene
Akeso
Chia Tai-Tianqing
Kura Oncology
Hoffmann-La Roche
Eli Lilly and Company
Published | Pages | Publisher | Report code |
---|---|---|---|
Sep 2022 | 239 | DelveInsight | ASDR-609109 |
CEL-SCI
Junshi Biosciences
Coherus
Exelixis
Immutep S.A.S.
Merck Sharp & Dohme LLC
Iovance Biotherapeutics
BeiGene
Akeso
Chia Tai-Tianqing
Kura Oncology
Hoffmann-La Roche
Eli Lilly and Company